Skip to main content
. Author manuscript; available in PMC: 2007 Sep 27.
Published in final edited form as: J Drug Target. 2006 Jun;14(5):321–329. doi: 10.1080/10611860600613316

Table I.

Effect of AT1002 on 3H ardeparin and 14C mannitol fluxes across Caco-2 cell monolayer.

AT1002 (%) 3H ardeparin (× 10−7 cm/s) 14C mannitol (× 10−7 cm/s) Enhancement ratio (ER) for ardeparin
0 2.8 ± 0.6 7.5 ± 3.1 1.0
0.0125 4.5 ± 0.2 10.4 ± 1.7 1.6
0.0250 5.9 ± 0.6 14.8 ± 1.0 2.1

Significantly different compared to control ( p < 0.05).